We are a global team of like-minded Med-Tech professionals focused on patient centric solutions in a collaborative environment leading to excellent outcomes. We have developed an advanced and unique heart failure therapy technology in the BrioVAD® Left Ventricular Assist System (LVAS). We are introducing the BrioVAD® LVAS to Heart Failure clinicians for use with the large number of indicated and untreated patients who could benefit from chronic mechanical circulatory support. The initiation of our INNOVATETM Trial in the US is only the beginning. We are building a team to develop advanced technology intended to further improve patient outcomes, increase therapy acceptance, and enabling chronic MCS therapy to be accessible to more patients across the globe. About the BrioVAD® Left Ventricular Assist System (LVAS)* Leveraging innovative pump design with long-blade rotor technology, the BrioVAD® LVAS has been designed to create an optimal blood flow path, boosting cardiac output, while minimizing complications. BrioVAD® LVAS’s patient-centric design enhances patient comfort and promotes a sense of vitality and improved well-being. *The BrioVAD® LVAS is an Investigational Device and limited by Federal law to investigational use.